We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

70 hedge funds and large institutions have $454M invested in Sio Gene Therapies Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 21

1% less funds holding

Funds holding: 71 → 70 (-1)

20% less call options, than puts

Call options by funds: $1.73M | Put options by funds: $2.15M

65% less capital invested

Capital invested by funds: $1.29B → $454M (-$837M)

Holders
70
Holders Change
-1
Holders Change %
-1.41%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
20
Increased
27
Reduced
13
Closed
21
Calls
$1.73M
Puts
$2.15M
Net Calls
-$426K
Net Calls Change
-$2.26M

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$13.6M
2
JP Morgan Chase
JP Morgan Chase
New York
+$5.78M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.67M
4
AC
Ascend Capital
California
+$3.53M
5
AFG
American Financial Group
Ohio
+$2.8M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$969M
2
DM
Deerfield Management
New York
-$6.26M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$5.76M
4
Franklin Resources
Franklin Resources
California
-$3.49M
5
Capstone Investment Advisors
Capstone Investment Advisors
New York
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Atika Capital Management
New York
$1.89M +$488K +3,750 +40%
Vanguard Group
27
Vanguard Group
Pennsylvania
$1.69M +$918K +7,055 +150%
State of New Jersey Common Pension Fund D
28
State of New Jersey Common Pension Fund D
New Jersey
$1.53M – – –
FCMI
29
Foresite Capital Management II
California
$1.17M – – –
Norges Bank
30
Norges Bank
Norway
$1.13M +$941K +7,234 +1,157%
BIM
31
BlackRock Investment Management
Delaware
$1.12M +$10.2K +78 +1%
NSEDCP
32
NJ State Employees Deferred Compensation Plan
New Jersey
$920K – – –
Bank of New York Mellon
33
Bank of New York Mellon
New York
$915K +$522K +4,009 +172%
NFA
34
Nationwide Fund Advisors
Ohio
$807K +$676K +5,195 +1,289%
TCIM
35
TIAA CREF Investment Management
New York
$761K – – –
Swiss National Bank
36
Swiss National Bank
Switzerland
$755K +$682K +5,238 New
BlackRock
37
BlackRock
New York
$631K -$96K -738 -14%
Morgan Stanley
38
Morgan Stanley
New York
$556K +$435K +3,344 +656%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$473K +$7.03K +54 +2%
TA
40
Teachers Advisors
New York
$387K +$115K +887 +49%
Charles Schwab
41
Charles Schwab
California
$354K +$319K +2,450 New
OPPM
42
Opus Point Partners Management
New York
$340K -$193K -1,483 -39%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$321K +$9.63K +74 +3%
Geode Capital Management
44
Geode Capital Management
Massachusetts
$310K +$61.3K +471 +28%
QSS
45
Quantitative Systematic Strategies
Florida
$301K +$254K +1,949 New
AP
46
Archon Partners
New Jersey
$234K +$211K +1,625 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$233K +$210K +1,613 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$225K +$203K +1,563 New
BCM
49
Bourgeon Capital Management
Connecticut
$180K -$163K -1,250 -50%
Wells Fargo
50
Wells Fargo
California
$147K +$131K +1,010 +14,429%
1
2
3 4

SIOX Hedge Fund Activity: Q4 2015 in Review

70 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q4 2015, worth a combined $454M — down 65% from $1.29B a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SIOX and 20 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 27 added.

The largest buyer was Janus Henderson Investors US, adding an estimated $13.6M. The largest seller was QVT Financial, exiting entirely with an estimated $969M sold.

  • 70 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q4 2015, down from 71 in Q3 2015.
  • Funds reported $454M of Sio Gene Therapies Inc. Common Stock stock for Q4 2015, down 65% quarter-over-quarter.
  • 20 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q4 2015 and 21 closed out, a net change of -1 holder.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q4 2015 was Janus Henderson Investors US, an estimated $13.6M added.
  • The largest Sio Gene Therapies Inc. Common Stock seller in Q4 2015 was QVT Financial, an estimated $969M sold.

Based on aggregated 13F filings for Q4 2015.